US EditionWarning about sharp rise in illegal medicines sold in the EU | European Medicines Agency (EMA)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
Pharma Deutschland e.V. [Newsroom]Berlin (ots) - Patients should not obtain medicines from unknown internet sources and should be advised in case of uncertainty in the pharmacy on site. The European Medicines Agency (EMA) and the Heads of Medicines ... Continue reading here...Original content of: Pharma Deutschland e.V., transmitted by news aktuell
The AGES warns against fraudulent websites and health risks. In recent months, the number of illegal medicines marketed to reduce weight and treat diabetes has increased significantly. They pose a serious health risk, the Agency for Health and Food Security (AGES) warns on its website. The products are often sold on fraudulent websites and advertised on social media. They are not approved and do not meet safety and efficacy standards.
The rise of the illegal market for slimming drugs is already one of the priorities of the pharmaceutical industry. The latest warning has come from health agencies, which have come closer to the height of the viralization of this type of drugs - GLP-1 receptor agonists- and which, as has been reported by Medical Writing in recent months, has its own black market.
The European Medicines Agency (EMA) and the Network of Heads of Medicines Agencies (HMA), of which the Spanish Medicines and Health Products Agency (AEMPS) is part, have warned of a sharp increase in the number of illegal drugs marketed as GLP-1 agonists used for weight loss and diabetes.
The European Medicines Agency (EMA) and the Network of Heads of Medicines Agencies (HMA), of which the Spanish Agency for Medicines and Health Products (AEMPS) is a member, have warned this Wednesday of the "growing threat" of the online advertising and sale of illegal drugs throughout the European Union. Fraud around weight loss drugs, such as the famous Ozempic, is of particular concern.
The National Institute for Drug Control (ŠÚKL) warns of the growing threat of counterfeit medicines for diabetes and obesity promoted and sold over the Internet throughout the European Union (EU). It warns that after taking them, patients are at risk of developing serious health problems or dangerous interactions with other medicines. The TASR was informed about this by ŠÚKL spokeswoman Lucia Balažiková. “In recent months, European authorities h…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
